CMEP 01C - Cervical Cancer Screening Online Course Implementation of the 2023 Guidelines
1214999
Delivery Options
Online Platform - Canvas
Loading...
Course Description
The Saskatchewan Cancer Agency (SCA), the Department of Obstetrics and Gynecology, and the Division of Continuing Medical Education (CME), College of Medicine, University of Saskatchewan have collaborated on a course aimed at providing a learning opportunity for practitioners on the revised 2023 Cervical Cancer Screening Clinical Practice Guidelines going into effect Monday, November 6, 2023.
Target Audience - All Pap providers in Saskatchewan (e.g. Family Physicians, OBGYNs, Nurse Practitioners, Advance Practice Nurses, Midwives).
Course Outline
By the end of the professional development course, the learner will be able to:
- Estimate the potential benefits and harms of cervical cancer screening among people of different age groups.
- Identify appropriate screening for special populations including people who are transgender or gender diverse, pregnant, post-hysterectomy, and immunosuppressed.
- Discuss the clinical advantages of introducing HPV reflex testing to routine cervical screening.
-
Describe how the 2023 Cervical Cancer Screening Clinical Practice Guidelines provide evidence-based, patient-centered cervical screening in Saskatchewan.
Modules
- Module 1: HPV Refles Testing
- Module 2: Screening Populations, Initiation, Interval, and Discontinuing
- Module 3: Management of Cervical Screening Test Results
- Module 4: Other Considerations Regarding Cervical Cancer Screening
- Module 5: Transitioning Patients from the 2012 to 2023 Cervical Cancer Screening Guideline
- Optional* Module 6: Screening Program for Cervical Cancer
- Optional* Module 7: HPV Immunization
Learner Outcomes
Upon completion of the module, participants will be able to:??
- Provide cervical screening for people who have been HPV vaccinated.
- Encourage HPV vaccination for all people ages 9 to 26 and for women up to age 45.
- Increase awareness of the HPV vaccine and its role in preventing HPV-associated cancers and benign diseases.
- Recognize variations in HPV vaccination funding coverage and refer those who need assistance to Public Health.
- Discuss the joint statement on HPV prevention by the Consortium for Infectious Disease Control, the Society of Obstetricians and Gynaecologists of Canada, the Society of Gynecologic Oncology of Canada, the Canadian Society of Otolaryngology-Head and Neck Surgeons, and the Canadian Association of Head and Neck Surgical Oncology.
Loading...
Enroll Now - Select a section to enroll in
Required fields are indicated by .